Endocrinology Practice Questions

Q: Diabetes mellitus is present in all of the following conditions except:

Fanconi anemia. **Explanation:** The correct answer is **Fanconi Anemia (A)**. While Fanconi Anemia is associated with various endocrine abnormalities (such as growth hormone deficiency and hypothyroidism), it is primarily a DNA repair defect leading to bone marrow failure and malignancy. It is **not** classically associated with Diabetes Mellitus. In contrast, the other three options are well-recognized genetic syndromes that feature insulin resistance or glucose intolerance [1], [2]. **Analysis of Options:** * **Noonan Syndrome (B):** This "male Turner-like" syndrome is associated with PTPN11 mutations. It carries an increased risk of metabolic disturbances, including hyperinsulinemia and an elevated risk of developing Diabetes Mellitus. * **Ataxia Telangiectasia (C):** This is a multisystem autosomal recessive disorder. A hallmark feature (besides cerebellar ataxia and telangiectasia) is **extreme insulin resistance** and progressive glucose intolerance, often manifesting as type 2-like diabetes [3]. * **Myotonic Dystrophy (D):** This trinucleotide repeat disorder (CTG) is famous for multisystem involvement. Endocrine features include frontal balding, testicular atrophy, and significant **insulin resistance** due to defects in insulin receptor splicing, leading to Diabetes Mellitus [3]. **High-Yield Clinical Pearls for NEET-PG:** * **Fanconi Anemia vs. Fanconi Syndrome:** Do not confuse the two. Fanconi *Anemia* is a marrow failure syndrome; Fanconi *Syndrome* is a proximal renal tubular defect. * **Syndromic Diabetes:** Always remember **Wolfram Syndrome (DIDMOAD)**: Diabetes Insipidus, Diabetes Mellitus, Optic Atrophy, and Deafness. * **Insulin Resistance Syndromes:** Other high-yield associations include **Alström syndrome**, **Leprechaunism (Donohue syndrome)**, and **Rabson-Mendenhall syndrome** [3].

Q: Which of the following is NOT true regarding Polyglandular Autoimmune Syndrome Type I?

It is associated with celiac disease.. Polyglandular Autoimmune Syndrome Type I (APS-1), also known as **APECED** (Autoimmune Polyendocrinopathy-Candidiasis-Ectodermal Dystrophy), is a rare genetic disorder characterized by a classic clinical triad [1]. **Why Option D is the correct answer:** Celiac disease is **not** a characteristic component of APS-1. Instead, it is strongly associated with **APS-2** (Schmidt Syndrome), which also includes Type 1 Diabetes Mellitus and Graves' disease/Hashimoto's thyroiditis [2]. **Analysis of other options:** * **Option A & B:** APS-1 is inherited in an **autosomal recessive** pattern. It is caused by a mutation in the **AIRE** (Autoimmune Regulator) gene, located on chromosome 21. This gene is crucial for the negative selection of self-reactive T-cells in the thymus; its defect leads to widespread autoimmunity. * **Option C:** APS-1 has several minor associations beyond the classic triad, including **chronic active hepatitis**, pernicious anemia, vitiligo, and asplenism. **Clinical Pearls for NEET-PG:** * **The Classic Triad (Must-know):** 1. Chronic Mucocutaneous Candidiasis (usually the first sign). 2. Hypoparathyroidism. 3. Addison’s Disease (Adrenal insufficiency) [1]. * **Diagnosis:** Requires at least 2 out of the 3 classic features (or only 1 if a sibling is affected). * **Ectodermal Dystrophy:** Look for enamel hypoplasia, nail pitting, and alopecia in the clinical vignette. * **Contrast with APS-2:** APS-2 is more common, occurs in adults, is polygenic (HLA-linked), and lacks candidiasis/hypoparathyroidism.

Q: Central diabetes insipidus is characterized by which of the following?

Low urine osmolality and high plasma osmolality. Central Diabetes Insipidus (DI) is caused by a deficiency in the synthesis or release of **Antidiuretic Hormone (ADH)** from the posterior pituitary. ADH normally acts on the V2 receptors in the renal collecting ducts to reabsorb water [1]. 1. **Why Option D is Correct:** In the absence of ADH, the kidneys cannot reabsorb water, leading to the excretion of large volumes of dilute urine. This results in **low urine osmolality** (typically 295 mOsm/kg). 2. **Why Other Options are Incorrect:** * **Option A & C:** Low plasma osmolality is characteristic of **Primary Polydipsia**, where excessive water intake suppresses ADH and dilutes the blood [2]. * **Option B:** High urine osmolality occurs in states of dehydration where ADH is functioning normally to conserve water. **NEET-PG High-Yield Pearls:** * **Water Deprivation Test:** The gold standard for diagnosis. In Central DI, urine osmolality remains low after dehydration but **increases by >50%** following the administration of exogenous desmopressin (dDAVP). * **Nephrogenic DI:** Unlike Central DI, there is **no response** to desmopressin because the defect lies in the renal receptors [2]. * **Most Common Cause:** Idiopathic is most common, followed by trauma/surgery to the pituitary-hypothalamic region [3]. * **MRI Finding:** Loss of the normal "posterior pituitary bright spot" on T1-weighted images is a classic sign of Central DI.

Q: Syndrome of inappropriate ADH secretion is commonly associated with which of the following malignancies?

Lung carcinoma. Explanation: Syndrome of Inappropriate Antidiuretic Hormone (SIADH) is a common paraneoplastic syndrome characterized by the autonomous, non-physiological secretion of ADH, leading to water retention and dilutional hyponatremia. Why Lung Carcinoma is Correct: Among all malignancies, Small Cell Lung Carcinoma (SCLC) is the most frequent cause of SIADH [1]. Approximately 7–10% of patients with SCLC develop SIADH because the neuroendocrine tumor cells ectopically produce and secrete arginine vasopressin (ADH) [1]. It is a classic high-yield association in clinical medicine. Analysis of Incorrect Options: * Breast and Ovarian Carcinoma: While these can occasionally be associated with paraneoplastic syndromes (like hypercalcemia of malignancy due to PTHrP), they are not classically or commonly associated with SIADH [1]. * Hepatocellular Carcinoma: This is more frequently associated with paraneoplastic erythrocytosis (due to EPO production) or hypoglycemia, but rarely SIADH [1]. NEET-PG High-Yield Pearls: * Most common cause of SIADH overall: Small Cell Lung Cancer (SCLC) [1]. * Diagnosis: Characterized by hyponatremia, low serum osmolality ( 100 mOsm/kg) in a euvolemic patient. * Management: The mainstay of treatment for chronic SIADH is fluid restriction. For symptomatic/severe hyponatremia, hypertonic saline (3%) is used. Vaptans (Vasopressin receptor antagonists) are pharmacological options. * Complication: Rapid correction of hyponatremia can lead to Osmotic Demyelination Syndrome (Central Pontine Myelinolysis). Remember: "Low to High, your Pons will die."

Q: Which type of diabetes is HLA associated?

Type I diabetes. **Explanation:** **Type 1 Diabetes Mellitus (T1DM)** is an autoimmune disorder characterized by the destruction of pancreatic beta cells [1]. Its pathogenesis is strongly linked to the **Major Histocompatibility Complex (MHC)**, specifically the **HLA class II genes** located on chromosome 6p21 [2]. * **Why Option A is correct:** Approximately 90–95% of children with T1DM carry the high-risk haplotypes **HLA-DR3-DQ2** or **HLA-DR4-DQ8**. These HLA molecules are responsible for presenting islet autoantigens to T-lymphocytes, triggering the autoimmune cascade [1]. Heterozygosity for both (DR3/DR4) confers the highest genetic risk. * **Why other options are incorrect:** * **Type 2 Diabetes (B):** This is primarily a metabolic disorder characterized by insulin resistance and relative insulin deficiency. While it has a stronger overall genetic component (higher concordance in identical twins) than T1DM, it is **polygenic** and not associated with HLA or autoimmune markers [1]. * **Malnutrition-related Diabetes (C):** Now largely classified under "Other specific types," this is associated with environmental factors (protein deficiency/cassava toxins) and pancreatic calcification, not HLA-mediated autoimmunity [3]. * **Pregnancy-related Diabetes (D):** Gestational Diabetes (GDM) is driven by placental hormones (like Human Placental Lactogen) causing insulin resistance; it does not have an HLA association. **High-Yield Clinical Pearls for NEET-PG:** 1. **Strongest Association:** HLA-DR3 and HLA-DR4 [1]. 2. **Protective Allele:** HLA-DQB1*0602 is known to provide protection against T1DM. 3. **Autoantibodies:** The presence of GAD65, IA-2, and Zinc Transporter 8 (ZnT8) antibodies confirms the autoimmune nature of T1DM [2]. 4. **LADA:** Latent Autoimmune Diabetes in Adults also shows HLA associations similar to T1DM.

Q: Brown tumour is seen in which of the following conditions?

Increased parathyroid hormone. **Explanation:** **Brown tumors** (also known as osteitis fibrosa cystica) are non-neoplastic bone lesions that occur as a direct complication of **Hyperparathyroidism** (specifically primary or tertiary) [1]. 1. **Why Option A is Correct:** Increased Parathyroid Hormone (PTH) stimulates excessive osteoclast activity [1]. This leads to rapid bone resorption and the replacement of normal marrow with vascular fibrous tissue [1]. Micro-hemorrhages occur within these cystic spaces; the subsequent breakdown of hemoglobin leaves behind **hemosiderin** deposits. This pigment gives the lesion its characteristic "brown" appearance under the microscope. 2. **Why Other Options are Incorrect:** * **Options B & C (Thyroxine/Thyroid Hormone):** While hyperthyroidism can cause increased bone turnover and osteoporosis, it does not lead to the formation of localized fibro-cystic brown tumors. * **Option D (Calcitonin):** Calcitonin is secreted by the parafollicular C-cells of the thyroid and acts to *inhibit* osteoclast activity (lowering blood calcium) [1]. High levels (often seen in Medullary Thyroid Carcinoma) do not cause bone resorption or brown tumors. **High-Yield Clinical Pearls for NEET-PG:** * **Radiological Hallmark:** Brown tumors appear as well-demarcated, expansile lytic lesions on X-ray. * **Classic Description:** "Salt and pepper" appearance of the skull and subperiosteal resorption of the phalanges (radial aspect of middle phalanges) are pathognomonic for hyperparathyroidism. * **Von Recklinghausen's Disease of Bone:** This is the historical name for the skeletal manifestations of severe hyperparathyroidism (not to be confused with NF-1). * **Management:** The primary treatment is surgical removal of the offending parathyroid gland; the bone lesions often regress spontaneously once PTH levels normalize.

Q: What is the treatment for lithium-induced diabetes insipidus?

Amiloride. Lithium-induced Diabetes Insipidus (DI) is the most common cause of drug-induced **Nephrogenic Diabetes Insipidus**. **Why Amiloride is the Correct Answer:** Lithium enters the principal cells of the collecting duct through **ENaC (Epithelial Sodium Channels)**. Once inside, lithium inhibits glycogen synthase kinase-3β (GSK-3β), which interferes with the action of ADH (Vasopressin) on its V2 receptors. This prevents the insertion of Aquaporin-2 channels, leading to polyuria. **Amiloride** is a potassium-sparing diuretic that specifically **blocks ENaC**. By blocking these channels, amiloride prevents lithium from entering the principal cells, thereby restoring the kidney's sensitivity to ADH and reducing polyuria. **Analysis of Incorrect Options:** * **A. Vasopressin:** This is the treatment for *Central* DI [1]. In lithium-induced DI, the kidneys are resistant to vasopressin; therefore, giving more will not resolve the issue [1]. * **B. Mineralocorticoid antagonist (e.g., Spironolactone):** These act on the aldosterone receptor but do not specifically block the entry of lithium through ENaC as effectively as amiloride. * **D. Loop diuretic (e.g., Furosemide):** These inhibit the Na-K-2Cl symporter in the Loop of Henle and would actually worsen dehydration and polyuria. **High-Yield Clinical Pearls for NEET-PG:** 1. **First-line management:** If possible, discontinue lithium. If lithium must be continued (e.g., for bipolar stability), **Amiloride** is the drug of choice. 2. **Thiazide Diuretics:** Paradoxically, Thiazides can also be used in Nephrogenic DI. They cause mild volume depletion, which increases proximal tubule reabsorption of water, reducing the volume delivered to the distal nephron. 3. **Monitoring:** Always monitor serum lithium levels, as diuretics can alter lithium clearance and potentially lead to toxicity.

Q: All are true regarding SIADH except:

Urine hypoosmolar. **Explanation:** **SIADH (Syndrome of Inappropriate Antidiuretic Hormone)** is characterized by the autonomous, non-physiological release of ADH, leading to excessive water reabsorption in the collecting ducts of the kidney [1]. **Why Option B is the correct answer (The "Except"):** In SIADH, the excess ADH causes maximum water retention, which results in highly concentrated urine [1]. Therefore, the urine is **hyperosmolar** (typically >100 mOsm/kg, and often > plasma osmolality), not hypoosmolar [1]. Finding dilute (hypoosmolar) urine in the presence of hyponatremia would instead point toward diagnoses like primary polydipsia [2]. **Analysis of Incorrect Options:** * **A. Increased level of ADH:** This is the primary pathophysiology. ADH levels are inappropriately high relative to low plasma osmolality [3]. * **C. Hyponatremia:** This is a hallmark feature. It is a **dilutional hyponatremia** caused by excessive water retention, not a true sodium deficiency [1]. * **D. Adequate hydration status:** SIADH patients are clinically **euvolemic** [2]. While there is water retention, the body compensates via pressure natriuresis (atrial natriuretic peptide release), which excretes sodium and water to prevent overt edema or hypertension. **NEET-PG High-Yield Pearls:** 1. **Diagnostic Criteria:** Hyponatremia + Low plasma osmolality ( 100 mOsm/kg) + High urine sodium (>40 mEq/L) [2]. 2. **Common Causes:** Small cell carcinoma of the lung (ectopic production), CNS disorders (stroke, trauma), and drugs (SSRIs, Carbamazepine, Cyclophosphamide). 3. **Management:** Fluid restriction is the first-line treatment. For refractory cases, use **Vaptans** (Vasopressin receptor antagonists) or Demeclocycline [3]. 4. **Caution:** Rapid correction of hyponatremia can lead to **Osmotic Demyelination Syndrome** (Central Pontine Myelinolysis).

Q: Which of the following is NOT true about autonomic neuropathy?

Bradycardia. **Explanation:** Autonomic neuropathy, most commonly seen in Diabetes Mellitus, involves damage to the nerves regulating involuntary body functions [1]. The correct answer is **Bradycardia** because autonomic dysfunction typically leads to the loss of vagal (parasympathetic) tone, which normally slows the heart rate [2]. **1. Why Bradycardia is NOT true:** In early cardiac autonomic neuropathy (CAN), there is a preferential loss of parasympathetic (vagal) innervation. This results in unopposed sympathetic activity, leading to **resting tachycardia** rather than bradycardia [2]. Furthermore, the heart rate becomes "fixed," meaning it does not respond normally to exercise, stress, or the Valsalva maneuver [2]. **2. Analysis of Incorrect Options:** * **Resting Tachycardia:** This is one of the earliest signs of CAN due to the withdrawal of vagal inhibition on the SA node [2]. * **Silent Myocardial Infarction:** Denervation of sensory afferent fibers in the myocardium prevents the transmission of pain signals. Consequently, patients may present with dyspnea or heart failure rather than classic angina. * **Orthostatic Hypotension:** This occurs due to the failure of the sympathetic nervous system to cause peripheral vasoconstriction and increase heart rate upon standing [2]. It is defined as a fall in systolic BP >20 mmHg or diastolic BP >10 mmHg upon standing. **High-Yield Clinical Pearls for NEET-PG:** * **Gastroparesis:** Another manifestation of autonomic neuropathy, leading to delayed gastric emptying and postprandial fullness [2]. * **Gustatory Sweating:** Excessive sweating while eating, often involving the face and neck [2]. * **Erectile Dysfunction:** Often the earliest clinical sign of autonomic neuropathy in men [2]. * **Bladder Dysfunction:** Leads to "cystopathy" (painless urinary retention and overflow incontinence) [2].

Question 1

Diabetes mellitus is present in all of the following conditions except:

Accepted Answer

Fanconi anemia

Answer

Noonan syndrome

Answer

Ataxia telangiectasia

Answer

Myotonic dystrophy

Question 2

Which of the following is NOT true regarding Polyglandular Autoimmune Syndrome Type I?

Accepted Answer

It is associated with celiac disease.

Answer

It is inherited in an autosomal recessive pattern.

Answer

It is caused by mutations in the APECED gene.

Answer

It is associated with chronic active hepatitis.

Question 3

Central diabetes insipidus is characterized by which of the following?

Accepted Answer

Low urine osmolality and high plasma osmolality

Answer

Low plasma and low urine osmolality

Answer

High plasma and high urine osmolality

Answer

Low plasma and high urine osmolality

Question 4

Syndrome of inappropriate ADH secretion is commonly associated with which of the following malignancies?

Accepted Answer

Lung carcinoma

Answer

Breast carcinoma

Answer

Ovarian carcinoma

Answer

Hepatocellular carcinoma

Question 5

In a woman with polyuria of 6L/day, which are the 2 most important investigations to be done?

Accepted Answer

Water deprivation test

Answer

Plasma and urine osmolality

Answer

Water loading test

Answer

Plasma osmolality

Question 6

Which type of diabetes is HLA associated?

Accepted Answer

Type I diabetes

Answer

Type II diabetes

Answer

Malnutrition-related diabetes

Answer

Pregnancy-related diabetes

Question 7

Brown tumour is seen in which of the following conditions?

Accepted Answer

Increased parathyroid hormone

Answer

Increased thyroxine

Answer

Increased thyroid hormone

Answer

Increased calcitonin

Question 8

What is the treatment for lithium-induced diabetes insipidus?

Accepted Answer

Amiloride

Answer

Vasopressin

Answer

Mineralocorticoid antagonist

Answer

Loop diuretic

Question 9

All are true regarding SIADH except:

Accepted Answer

Urine hypoosmolar

Answer

Increased level of ADH

Answer

Hyponatremia

Answer

Adequate hydration status

Question 10

Which of the following is NOT true about autonomic neuropathy?

Accepted Answer

Bradycardia

Answer

Resting tachycardia

Answer

Silent myocardial infarction

Answer

Orthostatic hypotension

Endocrinology — MCQs

Endocrinology — MCQs

On this page

Practice by Chapter

Want unlimited practice?